Bringing a medical device to market requires more than achieving regulatory approval. The decisions made early in product development can influence classification, clinical evidence, risk management, labeling, identification, and ultimately the entire market access strategy.
In this Easy Medical Device podcast collection, we focus on two important regulatory topics: defining a proper Intended Use and understanding Master UDI-DI.
Intended Use: The Foundation of Your Regulatory Strategy
Intended Use may look like a simple statement, but it can influence almost every part of a medical device's regulatory pathway.
A poorly defined Intended Use can create downstream problems with device classification, clinical evaluation, risk management, and regulatory submissions.
Even small changes in wording can have significant consequences, particularly for areas such as Software as a Medical Device (SaMD).
The discussion also explores a common misconception: manufacturers cannot simply use a disclaimer or change their labeling to avoid medical device regulation when the actual intended purpose and claims bring the product within the medical device framework.
Understanding Master UDI-DI
Device identification is another increasingly important part of regulatory strategy.
Master UDI-DI introduces an additional layer that MedTech manufacturers need to understand when managing device identification and regulatory information.
Understanding how it fits into the broader UDI framework can help manufacturers prepare their documentation and data strategy while avoiding mistakes that could create additional regulatory or operational work later.
Building a Stronger Market Access Strategy
Although Intended Use and Master UDI-DI address different regulatory challenges, they share an important principle: regulatory strategy should be considered early rather than treated as an administrative task at the end of development.
Clearly defining your device, understanding its regulatory implications, and preparing the right identification strategy can help create a more predictable path toward market access.
For Regulatory Affairs professionals and medical device manufacturers, these conversations provide practical insights into two topics that can significantly influence the regulatory journey from product development to market.
Who is Monir El Azzouzi?
Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.
Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com
If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.
Social Media to follow
Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi
Twitter: https://twitter.com/elazzouzim
Pinterest: https://www.pinterest.com/easymedicaldevice
Instagram: https://www.instagram.com/easymedicaldevice
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
